Crisaborole

克立硼罗

Report date: 2023/08/09 10:43:52
NME

Base Information

Drug NameCrisaborole
Drug Alias Namecrisaborolum克利保洛crisaborolEucrisaStaquis +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsPlaque psoriasisPsoriasisAlopecia Areata +[7] 
Global Approved IndicationsDermatitis, Atopic
Approved Indications in ChinaDermatitis, Atopic
Original Approved Country/TerritoryUnited States
Original Approved Date2016/12/14
Country/TerritoryCanadaUnited StatesPakistan +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAnacor Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of California IrvineShalamar Institute of Health SciencesPharmacia & Upjohn Company Llc +[8] 
Inactive CompaniesWake Forest University Health SciencesTufts Medical Center IncDuke University +[4] 
Active IndicationsEczemaDermatitisDermatitis, Atopic
Inactive IndicationsPlaque psoriasisPsoriasisAlopecia Areata +[4] 

Other Information

ATC CodeD11AH06
Related LinksWikipediaDrugBankKEGG